TSLP and allergic disease: In this study, we reported that YPFS significantly inhibited TSLP production in vivo and serum from YPFS-treated mice decreased TSLP production in vitro, which indicated that regulating TSLP is the underlying mechanism of YPFS in reducing allergy relapse.